|
US3340276A
(en)
|
1964-04-01 |
1967-09-05 |
Ciba Geigy Corp |
3, 4-diphenyl-chromans
|
|
DE1518002C3
(de)
|
1965-01-02 |
1975-01-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
DE1543749A1
(de)
|
1966-02-16 |
1969-12-11 |
Merck Ag E |
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
|
|
GB1433013A
(https=)
|
1973-06-08 |
1976-04-22 |
|
|
|
US4218489A
(en)
|
1977-06-08 |
1980-08-19 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4264509A
(en)
|
1977-06-08 |
1981-04-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4157984A
(en)
|
1977-06-08 |
1979-06-12 |
Z-L Limited |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4232122A
(en)
|
1979-01-17 |
1980-11-04 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4234577A
(en)
|
1979-03-19 |
1980-11-18 |
Z-L Limited Partnership |
Ergostadientriols, compositions containing same, and methods of preparing and using same
|
|
US4368264A
(en)
|
1979-03-19 |
1983-01-11 |
Z-L Limited Partnership |
Fermentation methods of preparing ergostadientriols
|
|
US4366082A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4366248A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Fermentation method of preparing antioxidants
|
|
US4390559A
(en)
|
1979-04-11 |
1983-06-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4447622A
(en)
|
1981-09-22 |
1984-05-08 |
Council Of Scientific And Industrial Research Rafi Marg |
Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
|
|
US4644012A
(en)
|
1983-12-21 |
1987-02-17 |
Takeda Chemical Industries, Ltd. |
Treatment for osteoporosis
|
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
|
US5059609A
(en)
|
1987-10-19 |
1991-10-22 |
Pfizer Inc. |
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
|
|
MX13485A
(es)
|
1987-10-19 |
1993-05-01 |
Pfizer |
Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
EP0470310B1
(en)
|
1990-08-09 |
1995-11-29 |
Council of Scientific and Industrial Research |
Novel benzopyrans and process for their production
|
|
PL308473A1
(en)
|
1992-10-21 |
1995-08-07 |
Pfizer |
Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids
|
|
US5451603A
(en)
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
|
US5280040A
(en)
|
1993-03-11 |
1994-01-18 |
Zymogenetics, Inc. |
Methods for reducing bone loss using centchroman derivatives
|
|
US5389646A
(en)
|
1993-12-30 |
1995-02-14 |
Zymogenetics, Inc. |
Methods for treatment and prevention of bone loss using 2,3-benzopyrans
|
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
HUP9702244A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
|
|
HUP9800133A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
|
|
CZ212397A3
(en)
|
1995-01-13 |
1997-11-12 |
Novo Nordisk As |
Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
|
|
TW448046B
(en)
|
1995-01-20 |
2001-08-01 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
|
|
CZ212097A3
(en)
|
1995-01-20 |
1997-11-12 |
Novo Nordisk As |
Use of 3,4-diphenylchromans for preparing a medicament intended for treating or prophylaxis of cerebral degenerative diseases
|
|
HUP9800297A3
(en)
|
1995-01-20 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
|
|
US5849461A
(en)
|
1995-08-01 |
1998-12-15 |
Shin-Etsu Chemical Co., Ltd. |
Chemically amplified positive resist composition
|
|
US5883118A
(en)
|
1996-01-11 |
1999-03-16 |
Nova Nordisk A/S |
Prostatic carcinoma
|
|
US5726202A
(en)
|
1996-01-11 |
1998-03-10 |
Novo Nordisk A/S |
Benign prostatic hypertrophy
|
|
US5747059A
(en)
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
|
IL124882A0
(en)
|
1996-01-11 |
1999-01-26 |
Novo Nordisk As |
Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
|
|
US5756539A
(en)
|
1996-07-11 |
1998-05-26 |
Novo Nordis A/S |
3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
|
|
EP0954307A1
(en)
|
1996-07-12 |
1999-11-10 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
|
|
WO1998002156A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
|
US5919817A
(en)
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
WO1998018776A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ZA979644B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
US5958967A
(en)
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5985306A
(en)
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
|
IL129627A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
AU744403B2
(en)
|
1996-10-28 |
2002-02-21 |
Novo Nordisk A/S |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
CA2270111A1
(en)
|
1996-10-28 |
1998-05-07 |
Lise Brown Christiansen |
Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US6043269A
(en)
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
CA2270113A1
(en)
|
1996-10-28 |
1998-05-07 |
Poul Jacobsen |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
JP2001502703A
(ja)
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
（−）―３，４―トランス―ジアリールクロマンの調製方法
|
|
US5994390A
(en)
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ZA979646B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
IL129618A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US6153768A
(en)
|
1996-12-13 |
2000-11-28 |
C & C Research Laboratories |
Benzopyran derivatives
|
|
ZA98682B
(en)
|
1997-01-29 |
1998-07-29 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
|
|
WO1998033500A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting senescence-associated motor impairment
|
|
AU5550298A
(en)
|
1997-01-29 |
1998-08-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
AUPP112497A0
(en)
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
|
WO1999049862A1
(en)
|
1998-03-30 |
1999-10-07 |
The University Of Mississippi |
Isoflavones for treating giardiasis and malaria
|
|
WO1999055898A1
(en)
|
1998-04-28 |
1999-11-04 |
Novo Nordisk A/S |
Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
|
|
FR2778404B1
(fr)
|
1998-05-06 |
2000-06-30 |
Hoechst Marion Roussel Inc |
Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
KR20000001793A
(ko)
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
AUPP868599A0
(en)
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
|
FR2789685B1
(fr)
|
1999-02-15 |
2001-05-04 |
Univ Lille Sciences Tech |
Procede de fabrication de polymeres solubles et insolubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s) et polymeres solubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s)
|
|
AUPQ008299A0
(en)
|
1999-04-30 |
1999-05-27 |
G.J. Consultants Pty Ltd |
Isoflavone metabolites
|
|
AU6315300A
(en)
|
1999-07-26 |
2001-02-13 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
WO2001026651A2
(en)
|
1999-10-14 |
2001-04-19 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
|
|
EP1241165A4
(en)
|
1999-12-13 |
2003-03-19 |
Chugai Pharmaceutical Co Ltd |
OPTICALLY ACTIVE CHROMAN AND THIOCHROME DERIVATIVES
|
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
CN1400904A
(zh)
|
2000-01-28 |
2003-03-05 |
恩多研究公司 |
与雌激素联合的选择性雌激素受体调节剂
|
|
WO2001085218A2
(en)
|
2000-05-11 |
2001-11-15 |
Eastman Chemical Company |
Acylated cyclodextrin guest inclusion complexes
|
|
FI20001593A7
(fi)
|
2000-07-03 |
2002-01-04 |
Orion Yhtymo Oyj |
Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
|
|
CN1250505C
(zh)
|
2000-08-31 |
2006-04-12 |
科学工业研究院 |
制备1－丙基－2，4，5－三甲氧基苯的改进方法
|
|
AU2002241823A1
(en)
|
2001-01-11 |
2002-07-24 |
Eastman Chemical Company |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
SK287086B6
(sk)
|
2001-01-24 |
2009-11-05 |
Chiesi Farmaceutici S.P.A. |
2H-1-Benzopyránové deriváty, farmaceutické prostriedky s ich obsahom a ich použitie
|
|
DE60211132T2
(de)
|
2001-02-14 |
2006-09-28 |
Akzo Nobel N.V. |
2-alkylierte cyclodextrin-derivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
|
|
WO2003016270A2
(en)
|
2001-08-11 |
2003-02-27 |
Bristol-Myers Squibb Pharma Company |
Selective estrogen receptor modulators
|
|
WO2003022994A2
(en)
|
2001-09-06 |
2003-03-20 |
Synorx, Inc. |
Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
|
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
|
EP1465619A1
(en)
|
2002-01-14 |
2004-10-13 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
|
CN1646119A
(zh)
|
2002-04-09 |
2005-07-27 |
诺沃根研究有限公司 |
涉及异黄－3－烯和异黄烷结构的治疗方法和组合物
|
|
AU2002951833A0
(en)
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
WO2004032862A2
(en)
|
2002-10-09 |
2004-04-22 |
Insert Therapeutics, Inc. |
Cyclodextrin-based materials, compositions and uses related thereto
|
|
JP2007511542A
(ja)
|
2003-11-18 |
2007-05-10 |
ノボゲン リサーチ ピーティーワイ リミテッド |
イソフラボノイドプロドラッグ、その組成物、それらを使用する治療法
|
|
CA2542351A1
(en)
|
2003-11-19 |
2005-06-02 |
Novogen Research Pty Ltd. |
Combinational radiotherapy and chemotherapy compositions and methods
|
|
DE102004002787A1
(de)
|
2004-01-19 |
2005-08-11 |
Merck Patent Gmbh |
Flavonoid-Komplexe
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
JP4976649B2
(ja)
|
2004-09-21 |
2012-07-18 |
マーシャル エドワーズ，インク． |
化合物
|
|
EP1794141B1
(en)
|
2004-09-21 |
2011-11-09 |
Marshall Edwards, Inc. |
Substituted chroman derivatives, medicaments and use in therapy
|
|
EP2436680B1
(en)
|
2004-09-21 |
2016-05-18 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
JP4913056B2
(ja)
|
2004-09-21 |
2012-04-11 |
マーシャル エドワーズ，インコーポレーテッド |
置換クロマン誘導体、医薬品、および治療における使用
|
|
AU2007314141A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
|
WO2008113100A1
(en)
|
2007-03-16 |
2008-09-25 |
Novogen Research Pty Ltd |
Method for inducing autophagy
|
|
CA2738328A1
(en)
|
2008-08-29 |
2010-03-04 |
Novogen Research Pty Ltd |
Immunomodulating activities
|
|
US20100130598A1
(en)
|
2008-10-22 |
2010-05-27 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
|
CA2641541A1
(en)
|
2008-10-22 |
2010-04-22 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
|
JP6013349B2
(ja)
|
2010-11-01 |
2016-10-25 |
メイ ファーマ, インク.Mei Pharma, Inc. |
癌の処置のためのイソフラボノイド化合物および方法
|
|
US20120251630A1
(en)
*
|
2011-03-29 |
2012-10-04 |
Marshall Edwards, Inc. |
Remission therapy of cancer with isoflavonoids
|
|
JP2015532272A
(ja)
|
2012-09-28 |
2015-11-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
二重アンジオポエチン−２／Ｄｌｌ４結合剤および抗ＶＥＧＦ−Ｒ剤を含む薬学的組み合わせ
|
|
WO2015117202A1
(en)
|
2014-02-07 |
2015-08-13 |
Novogen Limited |
Functionalised benzopyran compounds and use thereof
|
|
CN116139125A
(zh)
|
2015-02-02 |
2023-05-23 |
梅制药公司 |
联合治疗
|